NCT02154906

Brief Summary

Inflammatory periodontal disease often results in loss of bone around the teeth. Bone defects that have a certain size and shape (called intrabony or intraosseous defects) may be improved by using a graft material in the bony defect. The purpose of this study is to compare healing of periodontal intrabony defects that are treated using demineralized freeze dried bone allograft (DFDBA) versus autogenous platelet-rich fibrin. The null hypotheses is that there will be no significant differences in bone fill, CAL gain, PD reduction or recession at sites treated with PRF compared to sites treated with DFDBA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 29, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 3, 2014

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
2 months until next milestone

Results Posted

Study results publicly available

June 1, 2016

Completed
Last Updated

July 1, 2016

Status Verified

June 1, 2016

Enrollment Period

2.4 years

First QC Date

May 29, 2014

Results QC Date

April 23, 2016

Last Update Submit

June 1, 2016

Conditions

Keywords

periodontal diseaseperiodontitis

Outcome Measures

Primary Outcomes (1)

  • Change in Clinical Attachment Level (CAL)

    measurement of CAL at the time of surgical intervention will be compared with measurement of CAL and bone level 6 months after surgery

    baseline and 6 months after surgery

Secondary Outcomes (1)

  • Change in Radiographic Bone Level

    baseline and 6 months after surgery

Study Arms (2)

DFDBA

ACTIVE COMPARATOR

DFDBA used to graft intrabony defect

Device: DFDBA

autologous platelet rich fibrin

EXPERIMENTAL

autologous platelet rich fibrin used to graft intrabony defect

Device: autologous platelet rich fibrin

Interventions

DFDBADEVICE
DFDBA
autologous platelet rich fibrin

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient currently a patient at dental school or eligible for treatment at dental school
  • Patient resides within 50 mile radius of dental school and is eligible for treatment in Graduate Periodontics Clinic
  • Diagnosis of chronic periodontitis with a treatment plan that includes surgical treatment of an intrabony defect adjacent to a natural tooth
  • Willing and able to provide informed consent and be available for multiple follow-up visits for the duration of the study
  • One or more sites with 1) a probing depth of 6mm or greater (\>6mm), 2) a radiographic bony defect depth of greater than 3mm (\>3mm), 3) sufficient keratinized tissue to allow complete coverage of the defect with gingival flaps, and 4) radiographic base of bony defect at least 2mm coronal to the apex of the tooth
  • Female patients who have undergone a hysterectomy, tubal ligation or menopause, and non-pregnant women of child-bearing potential

You may not qualify if:

  • Failure to attain adequate oral hygiene prior to surgery (minimum 80% plaque-free surfaces)
  • History within the last 6 months of daily use of smokeless tobacco, pipe or cigar smoking, or cigarette smoking exceeding 10 cigarettes per day. Former smokers who quit more than 6 months before the study are eligible for enrollment. Current smokers who smoke less than 10 cigarettes per day are eligible for enrollment.
  • Untreated acute or chronic infections in the region of the study site
  • Tooth mobility of Grade 2 or higher at the tooth with the potential test site
  • Clinical or radiographic signs of apical pathology, root fracture, untreated carious lesions on the root surface or at the CEJ, subgingival restorations on the tooth with the potential test site
  • Sensitivity or allergy to Bacitracin, Gentamycin, Polymyxin B Sulfate, alcohol and/or surfactants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UT Health Science Center School of Dentistry

San Antonio, Texas, 78229, United States

Location

Related Publications (1)

  • Chadwick JK, Mills MP, Mealey BL. Clinical and Radiographic Evaluation of Demineralized Freeze-Dried Bone Allograft Versus Platelet-Rich Fibrin for the Treatment of Periodontal Intrabony Defects in Humans. J Periodontol. 2016 Nov;87(11):1253-1260. doi: 10.1902/jop.2016.160309. Epub 2016 Jun 28.

MeSH Terms

Conditions

PeriodontitisPeriodontal Diseases

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Results Point of Contact

Title
Brian L. Mealey
Organization
UT Health Science Center San Antonio

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 29, 2014

First Posted

June 3, 2014

Study Start

November 1, 2013

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

July 1, 2016

Results First Posted

June 1, 2016

Record last verified: 2016-06

Locations